tradingkey.logo
tradingkey.logo
Search

Bio Rad Laboratories Inc

BIO
Add to Watchlist
289.340USD
-5.960-2.02%
Market hours ETQuotes delayed by 15 min
7.76BMarket Cap
47.99P/E TTM

Bio Rad Laboratories Inc

289.340
-5.960-2.02%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-2.02%

5 Days

+2.93%

1 Month

-7.41%

6 Months

-4.74%

Year to Date

-4.51%

1 Year

+18.59%

Key Figures
297.010Open
299.320High
50.45KVolume
47.99P/E TTM
29.53P/E Dynamic
--Dividend TTM
0.19%Turnover Ratio
295.300Prev. Close
287.940Low
8.12MTurnover
LossP/E Static
1.13P/B
0.00%Div Yield TTM
1.75%ROA
343.12052wk High
0.27Volume Ratio
-1.84BNet Profit
26.83MShares
6.0298EPS TTM
1.09Beta
2.50%ROE
211.43052wk Low
3.85%Amplitude
52.25%Gross Margin
7.76BMarket Cap
-2.90Reward/Risk
1.90%Risk Rate

Key Insights

Bio Rad Laboratories Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 62 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 308.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bio Rad Laboratories Inc's Score

Industry at a Glance

Industry Ranking
62 / 204
Overall Ranking
164 / 4570
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Bio Rad Laboratories Inc Highlights

StrengthsRisks
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 48.97, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 18.42M shares, decreasing 18.53% quarter-over-quarter.
Held by John Rogers
Star Investor John Rogers holds 717.65K shares of this stock.

Analyst Rating

Based on 6 analysts
Hold
Current Rating
308.000
Target Price
+2.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bio Rad Laboratories Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bio Rad Laboratories Inc Info

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Ticker SymbolBIO
CompanyBio Rad Laboratories Inc
CEOSchwartz (Norman D)
Websitehttps://www.bio-rad.com/

FAQs

What is the current price of Bio Rad Laboratories Inc (BIO)?

The current price of Bio Rad Laboratories Inc (BIO) is 295.48.

What is the symbol of Bio Rad Laboratories Inc?

The ticker symbol of Bio Rad Laboratories Inc is BIO.

What is the 52-week high of Bio Rad Laboratories Inc?

The 52-week high of Bio Rad Laboratories Inc is 343.12.

What is the 52-week low of Bio Rad Laboratories Inc?

The 52-week low of Bio Rad Laboratories Inc is 211.43.

What is the market capitalization of Bio Rad Laboratories Inc?

The market capitalization of Bio Rad Laboratories Inc is 7.91B.

Is Bio Rad Laboratories Inc (BIO) currently rated as Buy, Hold, or Sell?

According to analysts, Bio Rad Laboratories Inc (BIO) has an overall rating of signal_hold, with a price target of 308.00.

What is the Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIO)?

The Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIO) is 27.87.
KeyAI